Atlas Trials

Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients

Clinical trial NCT00960349 · COMPLETED

Trial details

NCT number
NCT00960349
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2009-08-01
Primary completion
2010-01-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.